Your browser doesn't support javascript.
loading
Hijacking antibody-induced CTLA-4 lysosomal degradation for safer and more effective cancer immunotherapy.
Zhang, Yan; Du, Xuexiang; Liu, Mingyue; Tang, Fei; Zhang, Peng; Ai, Chunxia; Fields, James K; Sundberg, Eric J; Latinovic, Olga S; Devenport, Martin; Zheng, Pan; Liu, Yang.
Afiliação
  • Zhang Y; Divisions of Immunotherapy, University of Maryland Baltimore School of Medicine, Baltimore, MD, 21201, USA. yzhang@ihv.umaryland.edu.
  • Du X; Divisions of Immunotherapy, University of Maryland Baltimore School of Medicine, Baltimore, MD, 21201, USA.
  • Liu M; Divisions of Immunotherapy, University of Maryland Baltimore School of Medicine, Baltimore, MD, 21201, USA.
  • Tang F; Divisions of Immunotherapy, University of Maryland Baltimore School of Medicine, Baltimore, MD, 21201, USA.
  • Zhang P; Divisions of Immunotherapy, University of Maryland Baltimore School of Medicine, Baltimore, MD, 21201, USA.
  • Ai C; Divisions of Immunotherapy, University of Maryland Baltimore School of Medicine, Baltimore, MD, 21201, USA.
  • Fields JK; Divisions of Basic Science Division, Institute of Human Virology, University of Maryland Baltimore School of Medicine, Baltimore, MD, 21201, USA.
  • Sundberg EJ; Graduate Program in Molecular Microbiology and Immunology, University of Maryland Baltimore School of Medicine, Baltimore, MD, 21201, USA.
  • Latinovic OS; Divisions of Basic Science Division, Institute of Human Virology, University of Maryland Baltimore School of Medicine, Baltimore, MD, 21201, USA.
  • Devenport M; Department of Microbiology and Immunology, University of Maryland Baltimore School of Medicine, Baltimore, MD, 21201, USA.
  • Zheng P; Divisions of Basic Science Division, Institute of Human Virology, University of Maryland Baltimore School of Medicine, Baltimore, MD, 21201, USA.
  • Liu Y; Department of Microbiology and Immunology, University of Maryland Baltimore School of Medicine, Baltimore, MD, 21201, USA.
Cell Res ; 29(8): 609-627, 2019 08.
Article em En | MEDLINE | ID: mdl-31267017
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígeno CTLA-4 / Proteólise / Ipilimumab / Antineoplásicos Imunológicos / Imunoterapia / Lisossomos / Neoplasias Limite: Animals / Humans Idioma: En Revista: Cell Res Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígeno CTLA-4 / Proteólise / Ipilimumab / Antineoplásicos Imunológicos / Imunoterapia / Lisossomos / Neoplasias Limite: Animals / Humans Idioma: En Revista: Cell Res Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos